Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reactivating hope for TP53-mutated acute myeloid leukaemia?

The Lancet. Haematology - 1 Apr 2023

Bug Gesine

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Leukemia, Myeloid, Acute
Share to Mutation
Share to Tumor Suppressor Protein p53

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36990618
DOI: 10.1016/S2352-3026(23)00028-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reactivating hope for TP53-mutated acute myeloid leukaemia?PMID 36990618Read ↗

TP53 mutations in therapy-related acute myeloid leukemia: still the dark side of the moon?Semantic proximity Read ↗

p53 biology and reactivation for improved therapy in MDS and AMLSemantic proximity Read ↗

p53 Biology and Reactivation for Improved Therapy in MDS and AML–Are We Building Castles in the Air?Semantic proximity Read ↗

TP53 Mutations in Acute Leukemias and Myelodysplastic Syndromes: Insights and Treatment Updates.Semantic proximity Read ↗

Nontransplant treatment approaches for myeloid neoplasm with mutated TP53.Semantic proximity Read ↗

Navigating prognostic stratification and approach to TP53 -mutated myeloid neoplasms.Semantic proximity Read ↗

Progress in TP53-Deficient Chronic Lymphocytic Leukemia: More Questions Than Answers.Semantic proximity Read ↗

Somatic TP53 Mutations Drive T and NK Cell Dysfunction in AML and Can be Rescued by Reactivating Wild Type p53Semantic proximity Read ↗

Managing the unmanageable: evidence-driven approaches to real-world patient prototypes of TP53-mutant myelodysplastic neoplasms and acute myeloid leukemia.Semantic proximity Read ↗

Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia.Semantic proximity Read ↗

<i>TP53</i> mutations drive therapy resistance via post-mitochondrial caspase blockadeSemantic proximity Read ↗

Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.